Document Detail


Pathophysiology and treatment of septic shock in neonates.
MedLine Citation:
PMID:  20569817     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neonatal septic shock is a devastating condition associated with high morbidity and mortality. Definitions for the sepsis continuum and treatment algorithms specific for premature neonates are needed to improve studies of septic shock and assess benefit from clinical interventions. Unique features of the immature immune system and pathophysiologic responses to sepsis, particularly those of extremely preterm infants, necessitate that clinical trials consider them as a separate group. Keen clinical suspicion and knowledge of risk factors will help to identify those neonates at greatest risk for development of septic shock. Genomic and proteomic approaches, particularly those that use very small sample volumes, will increase our understanding of the pathophysiology and direct the development of novel agents for prevention and treatment of severe sepsis and shock in the neonate. Although at present antimicrobial therapy and supportive care remain the foundation of treatment, in the future immunomodulatory agents are likely to improve outcomes for this vulnerable population.
Authors:
James L Wynn; Hector R Wong
Related Documents :
2899587 - Influence of age on faecal carriage of p-fimbriated escherichia coli and other gram-neg...
3906547 - Rifampin and penicillin for the elimination of group b streptococci in nasally colonize...
6341847 - Penicillin in infants weighing two kilograms or less with early-onset group b streptoco...
21400487 - Head orientation and handedness trajectory in rhesus monkey infants (macaca mulatta).
3439947 - Hydrops foetalis in sheep.
11562617 - Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinics in perinatology     Volume:  37     ISSN:  1557-9840     ISO Abbreviation:  Clin Perinatol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-23     Completed Date:  2010-10-14     Revised Date:  2014-09-16    
Medline Journal Info:
Nlm Unique ID:  7501306     Medline TA:  Clin Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  439-79     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute-Phase Proteins / immunology
Anti-Infective Agents / therapeutic use
Blood Coagulation Disorders / immunology,  physiopathology
Complement System Proteins / immunology
Endothelium, Vascular / immunology
Genomics / methods
Humans
Hydrocortisone / therapeutic use
Immunity, Innate
Immunity, Maternally-Acquired
Infant, Newborn
Intercellular Signaling Peptides and Proteins / immunology
Multiple Organ Failure / immunology,  microbiology,  physiopathology,  therapy
Neutrophils / immunology
Opsonin Proteins / immunology
Proteomics / methods
Resuscitation / methods*
Risk Factors
Shock, Septic / immunology,  microbiology,  physiopathology*,  therapy*
Signal Transduction
Grant Support
ID/Acronym/Agency:
R01 GM064619/GM/NIGMS NIH HHS; R01 GM064619-06/GM/NIGMS NIH HHS; RC1 HL100474/HL/NHLBI NIH HHS; RC1 HL100474-01/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Acute-Phase Proteins; 0/Anti-Infective Agents; 0/Intercellular Signaling Peptides and Proteins; 0/Opsonin Proteins; 9007-36-7/Complement System Proteins; WI4X0X7BPJ/Hydrocortisone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis.
Next Document:  Adjunctive immunologic interventions in neonatal sepsis.